Sarah Waliany, MD, MS
@SWaliany
Followers
1K
Following
2K
Statuses
404
Heme/Onc Fellow @MGHCancerCenter @DanaFarber | IM Residency & Chief Res @StanfordMedRes | MD & MS @StanfordMed | Interests: #ThoracicOncology #TargetedTherapies
Joined June 2019
RT @JessicaJLinMD: Are you getting ready for #TTLC2025? Here is a quick yes/no poll for the #LCSM community and colleagues: Should all tar…
0
7
0
RT @LeXiuning: 📖Cancer statistics, 2025. 👉For the first time, the number of newly diagnosed female lung cancer cases has surpassed that of…
0
70
0
RT @LeciaSequist: This is a GREAT initiative! If you are a patient living with lung cancer, please contribute to this effort! 🙏🏽☑️💪🏽
0
8
0
RT @TLCconference: Join us for the Texas Lung Cancer Conference, co-chaired by Drs. @StephenVLiu and Tina Cascone! This 2-day CE accredited…
0
11
0
@FawziAbuRous @LaFontaineAuto @ShirishGadgeel @HenryFordHealth @LungCancerRx @HFHemOncFellows @IMG_Oncologists @HemOncFellows Congrats, Fawzi!!! So well-deserved! 🎉
0
0
1
RT @StephenVLiu: Such an amazing group of trainees and junior faculty at the 2024 @EGFRResisters Research Summit @EGFRSummit. It’s a privil…
0
5
0
RT @EGFRSummit: @SWaliany of @MGHCancerCenter @MassGeneralNews presents "Lung Carcinoid Tumors with Potentially Actionable Genomic Alterat…
0
7
0
RT @fangdisun: Thank you to @EGFRSummit @EGFRResisters @ZPiotrowskaMD @HelenaYu923 @StephenVLiu @maryjofidlerMD for bringing us together, o…
0
5
0
RT @StephenVLiu: Durvalumab now FDA approved for limited stage #SCLC based on the phase III ADRIATIC trial showing a PFS and an OS benefit…
0
21
0
RT @JACCJournals: Preventing, detecting & managing cancer therapy-related CV toxicity is clear objective during cancer Tx. #JACCCardioOnc e…
0
16
0
@Jia_Luo @NarjustFlorezMD @ALKPositiveinc @ALKpositiveINT @JessicaJLinMD @LeciaSequist Thank you, Dr. @NarjustFlorezMD and Dr. @Jia_Luo! Grateful for the opportunity to present these findings!
0
0
2
RT @NarjustFlorezMD: Dr. @SWaliany is one of our abstract award winners for the DF/HCC lung cancer symposium - she discussed mechanisms of…
0
4
0
RT @JustinGainor: Join me and our amazing faculty at our annual CME - "Advances in Cancer Immunotherapy" on Nov 14-15th. Registration is no…
0
2
0
RT @MassGeneralNews: Mass General and @harvardmed Investigator Gary Ruvkun, PhD, has won the 2024 @NobelPrize in Physiology or Medicine. He…
0
135
0
RT @KatieKeaneMD: Excited to present our Phase II trial of SBRT in patients with oncogene-driven #NSCLC 🫁 #ASTRO24 @MGHCancerCenter @Hennin…
0
6
0
RT @StephenVLiu: For those implementing the MARIPOSA-2 regimen of amivantamab + chemotherapy in #EGFR NSCLC post-osimertinib, highlighting…
0
41
0
@PoonamHosamani @ecvasti @cksantiago_MD This photo gives me so much happiness! 🥲 Missing you all too!
1
0
2
RT @MGHSurgery: Dr. Chi-Fu Jeffrey Yang (@chifujeffyang) is being featured in the MGB "We're One Against Cancer" Campaign. Congratulations…
0
6
0